2026 Global: Microcatheter In Pci Market -Competitive Review (2032) report
Description
The 2026 Global: Microcatheter In Pci Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Terumo Corporation, headquartered in Tokyo, Japan, is a leading developer of interventional devices, including a broad range of microcatheters used in PCI. Its Progreat microcatheter line is widely used to facilitate selective catheterization and guide-wire techniques in complex lesions. Asahi Intecc Co., Ltd., based in Osaka, Japan, is another major supplier of high-performance microcatheters, known for CTO-friendly designs and specialized tip configurations that enhance trackability and support. Merit Medical Systems, Inc., headquartered in South Jordan, Utah, United States, is a global medical device company offering a diverse portfolio of microcatheters and delivery systems for coronary and peripheral interventions. Medtronic plc, headquartered in Dublin, Ireland, maintains a significant PCI footprint through its microcatheter products and supportive accessories integrated with its broader interventional portfolio. Beyond primary devices, these firms invest in coatings, materials science, and compatibility with angiography workflows to optimize patient outcomes in complex coronary disease and CTO success globally.
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, United States, is a major global provider of PCI devices, including a broad spectrum of microcatheters designed to support complex lesion crossing and targeted drug delivery. Its microcatheter lines emphasize torque response, kink resistance, and compatibility with contemporary guidewires, enabling successful CTO interventions and precise selective catheterization in challenging coronary anatomies. Cardinal Health, Inc. (Cordis), headquartered in Dublin, Ohio, United States, markets Cordis interventional products, including a line of microcatheters engineered for navigability through tortuous arteries and reliable support for distal vessel access and device delivery. B. Braun Melsungen AG, headquartered in Melsungen, Germany, furnishes microcatheters as part of its cardiovascular portfolio, with an emphasis on biocompatible materials, hydrophilic coatings, and shaft designs that balance flexibility and pushability for rapid procedural workflow. Together, these firms drive standardization, training, and global access to advanced microcatheter technologies in PCI. Fostering collaboration across clinicians and regulators today.
Stryker Corporation, headquartered in Kalamazoo, Michigan, United States, provides a vascular interventional portfolio that includes microcatheters designed for durable performance and predictable navigation in complex coronary anatomy. Its devices are integrated with imaging and guidewire systems to streamline PCI workflows and support rapid procedural decisions. Cook Medical, headquartered in Bloomington, Indiana, United States, manufactures microcatheters for PCI alongside a wide range of endovascular products, emphasizing radiopacity, compatible shaft designs, and broad product availability across regional markets. Nipro Corporation, headquartered in Osaka, Japan, markets microcatheters and related interventional devices through its global Nipro Medical division, leveraging manufacturing scale and regional distribution networks to support access to coronary therapies in Asia Pacific, Europe, and the Americas.
Terumo Corporation, headquartered in Tokyo, Japan, is a leading developer of interventional devices, including a broad range of microcatheters used in PCI. Its Progreat microcatheter line is widely used to facilitate selective catheterization and guide-wire techniques in complex lesions. Asahi Intecc Co., Ltd., based in Osaka, Japan, is another major supplier of high-performance microcatheters, known for CTO-friendly designs and specialized tip configurations that enhance trackability and support. Merit Medical Systems, Inc., headquartered in South Jordan, Utah, United States, is a global medical device company offering a diverse portfolio of microcatheters and delivery systems for coronary and peripheral interventions. Medtronic plc, headquartered in Dublin, Ireland, maintains a significant PCI footprint through its microcatheter products and supportive accessories integrated with its broader interventional portfolio. Beyond primary devices, these firms invest in coatings, materials science, and compatibility with angiography workflows to optimize patient outcomes in complex coronary disease and CTO success globally.
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, United States, is a major global provider of PCI devices, including a broad spectrum of microcatheters designed to support complex lesion crossing and targeted drug delivery. Its microcatheter lines emphasize torque response, kink resistance, and compatibility with contemporary guidewires, enabling successful CTO interventions and precise selective catheterization in challenging coronary anatomies. Cardinal Health, Inc. (Cordis), headquartered in Dublin, Ohio, United States, markets Cordis interventional products, including a line of microcatheters engineered for navigability through tortuous arteries and reliable support for distal vessel access and device delivery. B. Braun Melsungen AG, headquartered in Melsungen, Germany, furnishes microcatheters as part of its cardiovascular portfolio, with an emphasis on biocompatible materials, hydrophilic coatings, and shaft designs that balance flexibility and pushability for rapid procedural workflow. Together, these firms drive standardization, training, and global access to advanced microcatheter technologies in PCI. Fostering collaboration across clinicians and regulators today.
Stryker Corporation, headquartered in Kalamazoo, Michigan, United States, provides a vascular interventional portfolio that includes microcatheters designed for durable performance and predictable navigation in complex coronary anatomy. Its devices are integrated with imaging and guidewire systems to streamline PCI workflows and support rapid procedural decisions. Cook Medical, headquartered in Bloomington, Indiana, United States, manufactures microcatheters for PCI alongside a wide range of endovascular products, emphasizing radiopacity, compatible shaft designs, and broad product availability across regional markets. Nipro Corporation, headquartered in Osaka, Japan, markets microcatheters and related interventional devices through its global Nipro Medical division, leveraging manufacturing scale and regional distribution networks to support access to coronary therapies in Asia Pacific, Europe, and the Americas.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
